Author:
Abulimite Zulipiyan,Mu Xiaojing,Xiao Shangyou,Liu Min,Li Quandan,Chen Gang
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference39 articles.
1. Durrington, P. N., Mackness, B., & Mackness, M. I. (2001). Paraoxonase and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 473–480.
2. Gan, K., Smolen, A., Eckerson, H. W., & La Du, B. N. (1991). Purification of human serum paraoxonase arylesterase-evidence for one esterase catalyzing both activities. Drug Metabolism and Disposition, 19, 100–106.
3. Mackness, M. I., Arrol, S., & Durrington, P. N. (1991). Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Letters, 286, 152–154.
4. Aydin, S., Sahin, I., Aydin, S., Aksoy, A., & Citil, C. (2012). The past and present of paraoxonase enzyme: its role in the cardiovascular system and some diseases. Journal of Medical Biochemistry, 31, 161–173.
5. Mehdi, M. M., & Rizvi, S. I. (2012). Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation. Archives of Medical Research, 43, 438–443.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献